New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Sanofi

SNY

Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue
+13.9%
EPS
+8.21%
Free cash flow
+99.6%
Total debt
−11.2%

Quarter to September 2026, against a year earlier

46.62 0.56 +1.22%
Market cap
$111.3B
P/E
22.8×
Fwd P/E FY26e
—
Dividend yield
5.25%
F-score
7/9
ROIC
7.05%
Net debt / EBITDA
0.8×
Payout ratio
1.2×

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It owes $12.4B more in debt than it holds in cash and short-term investments. Shareholders’ equity is 56.6% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $143.5B

Owns

$108.4BLong-term assets
$26.4BOther short-term assets
$8.7BCash & short-term investments

Funded by

$81.1BShareholders’ equity
$41.3BOther liabilities
$21.0BDebt

Debt is 14.7% of the total; shareholders’ equity 56.6%.

Net debt has held near 9% of assets since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$115.8B$112.8B$131.6B$126.3B$130.8B$142.3B$133.5B$136.9B$143.7B$143.5B
Net debt (debt less cash)$9.2B$6.0B$20.9B$17.1B$9.8B$12.1B$6.6B$8.3B$9.3B$12.4B
Net debt ÷ assets (right axis)7.9%5.3%15.9%13.5%7.5%8.5%5.0%6.1%6.4%8.6%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
35,019.09 46,084.48 33,194.14 35,849.79 36,160.27 38,498.94 32,044.32 29,027.80 29,785.67 29,531.83
Total non-current assets
108,448.10 97,616.24 103,677.90 97,664.50 106,098.00 92,327.54 94,220.00 102,545.00 83,047.66 86,298.20
Total Assets
143,467.20 143,700.70 136,872.00 133,514.30 142,258.30 130,826.50 126,264.30 131,572.80 112,833.30 115,830.00
Total current liabilities
32,069.53 31,556.20 26,185.17 25,248.47 25,194.12 21,986.99 22,826.72 20,521.06 17,471.05 18,185.87
Total non-current liabilities
30,264.95 27,895.46 30,214.57 29,085.68 35,393.62 36,706.66 37,236.64 41,331.46 29,513.26 33,766.79
Total liabilities
62,334.48 59,451.66 56,399.73 54,334.15 60,587.73 58,693.66 60,063.36 61,852.51 46,984.31 51,952.66
Common Equity (Total)
81,132.70 84,249.06 80,472.24 79,180.16 81,670.58 72,132.81 66,200.97 69,720.34 65,849.02 63,877.38
Shareholders Equity (Total)
81,132.70 84,249.06 80,472.25 79,180.15 81,670.58 72,132.82 66,200.96 69,720.34 65,849.02 63,877.38
Total Debt
21,032.73 17,313.60 17,741.06 20,051.06 24,024.03 25,715.45 27,647.20 29,099.84 17,633.81 20,559.52

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 5, 2026